Kanoknetr Suksen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kanoknetr Suksen has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Arthit Chairoungdua
Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand
2 shared publications - Boon-Ek Yingyongnarongkul
Department of Chemistry and Center of Excellence for Innovation in Chemistry, Faculty of Science, Ramkhamhaeng University, Bangkapi, Bangkok 10240, Thailand
1 shared publication - Duangrat Tantikanlayaporn
Division of Cell Biology, Department of Preclinical Science, Faculty of Medicine, Thammasat University, Pathumthani 12120, Thailand
1 shared publication - Laongthip Ruknarong
Center of Excellence in Stem Research and Innovation, Faculty of Medicine
1 shared publication - Mintra Kaewkittikhun
Center of Excellence in Stem Cell Research, Thammasat University, Pathumthani 12120, Thailand
1 shared publication - Nittaya Boonmuen
Department of Physiology, Faculty of Science
1 shared publication
Latest Publications
- 3 May 2023
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 86 (5) , 1335-1344
Genipin Analogue (G300) Inhibits Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through the Suppression of Adipogenic Promoting Factors
While obesity is a well-known health threatening condition worldwide, effective pharmacological interventions for obesity suppression have been limited due to adverse effects. Therefore, it is important to explore alternative medical treatments for combating obesity. Inhibition of the adipogenesis process and lipid accumulation are critical targets for controlling and treating obesity. Gardenia jasminoides Ellis is a traditional herbal remedy for various ailments. A natural product from its fruit, genipin, has major pharmacological properties; it is anti-inflammatory and antidiabetic. We investigated the effects of a genipin analogue, G300, on adipogenic differentiation in human bone marrow mesenchymal stem cells (hBM-MSCs). G300 suppressed the expression of adipogenic marker genes and adipokines secreted by adipocytes at concentrations of 10 and 20 mu M, which effectively reduced the adipogenic differentiation of hBM-MSCs and lipid accumulation in adipocytes. It also improved adipocyte function by lowering inflammatory cytokine secretion and increasing glucose uptake. For the first time, we show that G300 has the potential to be a novel therapeutic agent for the treatment of obesity and its related disorders.
- 3 May 2023
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 86 (5) , 1335-1344
Genipin Analogue (G300) Inhibits Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells through the Suppression of Adipogenic Promoting Factors
While obesity is a well-known health threatening condition worldwide, effective pharmacological interventions for obesity suppression have been limited due to adverse effects. Therefore, it is important to explore alternative medical treatments for combating obesity. Inhibition of the adipogenesis process and lipid accumulation are critical targets for controlling and treating obesity. Gardenia jasminoides Ellis is a traditional herbal remedy for various ailments. A natural product from its fruit, genipin, has major pharmacological properties; it is anti-inflammatory and antidiabetic. We investigated the effects of a genipin analogue, G300, on adipogenic differentiation in human bone marrow mesenchymal stem cells (hBM-MSCs). G300 suppressed the expression of adipogenic marker genes and adipokines secreted by adipocytes at concentrations of 10 and 20 mu M, which effectively reduced the adipogenic differentiation of hBM-MSCs and lipid accumulation in adipocytes. It also improved adipocyte function by lowering inflammatory cytokine secretion and increasing glucose uptake. For the first time, we show that G300 has the potential to be a novel therapeutic agent for the treatment of obesity and its related disorders.
- 20 July 2013
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 39 (4) , 444-450
In vitro delivery of curcumin with cholesterol-based cationic liposomes
A new cholesterol-based cationic lipid was synthesized; liposomes prepared on its basis were evaluated as drug delivery vehicles for curcumin. Free and liposome-encapsulated curcumin cytotoxicity against HeLa, A549, HepG2, K562 and 1301 cell lines was assessed. Liposomal curcumin with ED50 values ranging from 2.5–10 μM exhibited 2–8 times higher cytotoxicity than free curcumin. The synthetic cholesterol-based cationic lipid also enhanced cellular uptake of curcumin into tested cells. Cationic liposome alone showed low cytotoxicity at high doses with ED50 values of 90–210 μM.
- 20 July 2013
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 39 (4) , 444-450
In vitro delivery of curcumin with cholesterol-based cationic liposomes
A new cholesterol-based cationic lipid was synthesized; liposomes prepared on its basis were evaluated as drug delivery vehicles for curcumin. Free and liposome-encapsulated curcumin cytotoxicity against HeLa, A549, HepG2, K562 and 1301 cell lines was assessed. Liposomal curcumin with ED50 values ranging from 2.5–10 μM exhibited 2–8 times higher cytotoxicity than free curcumin. The synthetic cholesterol-based cationic lipid also enhanced cellular uptake of curcumin into tested cells. Cationic liposome alone showed low cytotoxicity at high doses with ED50 values of 90–210 μM.